| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/10/1997 | EP0793723A2 New staphylokinase derivatives |
| 09/10/1997 | EP0793722A2 Modified proteinase inhibitors |
| 09/10/1997 | EP0793721A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 09/10/1997 | EP0793720A2 Hemoglobin receptors from neisseriae |
| 09/10/1997 | EP0793677A1 Anti-inflammatory cd14 polypeptides |
| 09/10/1997 | EP0793676A1 Novel membrane proteins of helicobacter pylori |
| 09/10/1997 | EP0793675A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 09/10/1997 | EP0793674A1 Human neutrophil elastase inhibitors |
| 09/10/1997 | EP0793673A1 Alpha-ketoamide derivatives as cathepsin l inhibitor |
| 09/10/1997 | EP0793643A1 Matrix metalloprotease inhibitors |
| 09/10/1997 | EP0793506A1 Cellular and serum protein anchors and conjugates |
| 09/10/1997 | EP0793505A1 Medicaments comprising relaxin and their use |
| 09/10/1997 | EP0793504A1 Chimeric cytokines and uses thereof |
| 09/10/1997 | EP0793503A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
| 09/10/1997 | EP0793502A1 Novel hedgehog-derived polypeptides |
| 09/10/1997 | EP0793501A1 In vivo activation of tumor-specific cytotoxic t cells |
| 09/10/1997 | EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 09/10/1997 | EP0793472A1 Method of using lectins for agglutination and collection of menstrual flow |
| 09/10/1997 | EP0793418A1 Germicidal detergent-iodine compositions including polyvinyl pyrrolidone and compatible nonionic surfactant complexors |
| 09/10/1997 | EP0699073A4 Allogeneic and xenogeneic transplantation |
| 09/10/1997 | EP0695188A4 Novel bowman-birk inhibitor product for use as an anticarcinogenesis agent |
| 09/10/1997 | EP0689454B1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/10/1997 | EP0669001B1 Determination of peptide motifs on mhc molecules |
| 09/10/1997 | EP0636140B1 Partially modified and retro-inverted tetrapeptides analogues of c-reactive protein fragments |
| 09/10/1997 | EP0558635B1 Improved matrix metalloprotease inhibitors |
| 09/10/1997 | EP0553357B1 Novel prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors |
| 09/10/1997 | EP0546073B1 production and use of transgenic non-human animals capable of producing heterologous antibodies |
| 09/10/1997 | EP0466833B1 Protease inhibitor |
| 09/10/1997 | CN1159197A Purified form of streptogramines, preparation thereof and pharmacueitcal compositions containing it |
| 09/10/1997 | CN1159196A Inhibitors of interleukin-1'beta' converting enzyme |
| 09/10/1997 | CN1158896A Novel stress proteins |
| 09/10/1997 | CN1158856A Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/10/1997 | CN1158725A Use of 8,9-dehydroestrone as antioxidant |
| 09/10/1997 | CN1035801C Microgranular preparation useful in delivery of biologically active materials to intestinal regious of animals |
| 09/09/1997 | US5665870 Method of purifying keratinocyte growth factor (KGF) |
| 09/09/1997 | US5665869 Heating |
| 09/09/1997 | US5665864 Antibodies to a human integrin alpha/beta heterodimeric protein |
| 09/09/1997 | US5665863 Coupled to albumin; genetic engineering |
| 09/09/1997 | US5665862 Neurotrophic factor |
| 09/09/1997 | US5665861 Cardiodilatin fragment, process for preparing same and use thereof |
| 09/09/1997 | US5665860 Tetrapeptide amides |
| 09/09/1997 | US5665859 Molecules influencing the shedding of the TNF receptor, their preparation and their use |
| 09/09/1997 | US5665772 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 09/09/1997 | US5665761 Infusion of less than 6 hours |
| 09/09/1997 | US5665713 Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| 09/09/1997 | US5665706 Nerve growth factor and 2-amino-1,1,3-tricyano-1-propene |
| 09/09/1997 | US5665705 Adjuncts to insulin therapy |
| 09/09/1997 | US5665704 Receptor specific atrial natriuretic peptides |
| 09/09/1997 | US5665703 GE3 compound |
| 09/09/1997 | US5665702 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 09/09/1997 | US5665700 Pharmaceutical formulations |
| 09/09/1997 | US5665593 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 09/09/1997 | US5665591 Regulation of smooth muscle cell proliferation |
| 09/09/1997 | US5665588 DNA encoding natural killer lytic associated protein |
| 09/09/1997 | US5665580 Antisense oligonucleotide inhibition of papillomavirus transformed cells |
| 09/09/1997 | US5665577 Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof |
| 09/09/1997 | US5665569 HIV immunotherapeutics |
| 09/09/1997 | US5665568 Nucleic acid encoding the mature βA chain of inhibin and method for synthesizing polypeptides using such nucleic acid |
| 09/09/1997 | US5665567 Platelet-derived growth factor |
| 09/09/1997 | US5665566 Cloning of enterokinase and method of use |
| 09/09/1997 | US5665553 Methods for determining and modulating cellular redox potential and genotoxic states |
| 09/09/1997 | US5665552 Antibodies to plasmodium falciparum |
| 09/09/1997 | US5665550 Genes and genetic elements associated with sensitivity to chemotherapeutic drugs |
| 09/09/1997 | US5665548 Characterization and detection of sequences associated with autoimmune diseases |
| 09/09/1997 | US5665539 Immuno-polymerase chain reaction system for antigen detection |
| 09/09/1997 | US5665537 Testing human body fluids for antibodies |
| 09/09/1997 | US5665535 Polypeptides encoded by DNA sequences derived from the genome of the papillomavirus HPV39, antibodies thereto, and their use in in vitro diagnosis |
| 09/09/1997 | US5665428 Preparation of peptide containing biodegradable microspheres by melt process |
| 09/09/1997 | US5665389 Insulin, vibrio cholera zonula occludens toxin |
| 09/09/1997 | US5665387 Methods and compositions for primary and secondary prevention of autoimmune diabetes |
| 09/09/1997 | US5665386 Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| 09/09/1997 | US5665380 Lipid vesicle fusion as a method of transmitting a biologically active material to a cell |
| 09/09/1997 | US5665373 Prostaglandins, thromboxanes and leukotriene healing agents |
| 09/09/1997 | US5665372 Autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 09/09/1997 | US5665366 Applying one or more stratum corneum trypsin-like enzyme for dry flaky skin conditions, dandruff or acne |
| 09/09/1997 | US5665357 Antibodies recognizing tumor associated antigen CA 55.1 |
| 09/09/1997 | US5665356 Human anti-Rh (D) monoclonal antibodies |
| 09/09/1997 | US5665347 Treating autoimmune diseases |
| 09/09/1997 | US5665346 Human interleukin-8 analogs |
| 09/09/1997 | US5665345 Interleukin-10 |
| 09/09/1997 | CA1339447C Recombinant purified protease nexin |
| 09/09/1997 | CA1339445C Recombinant hybrid immunoglobulin molecules and method of use |
| 09/04/1997 | WO1997032033A1 Compositions and methods of making embryonic stem cells |
| 09/04/1997 | WO1997032029A1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 09/04/1997 | WO1997032026A1 Adapter molecules for targeting viral particles to cells |
| 09/04/1997 | WO1997032024A1 Allele suppression |
| 09/04/1997 | WO1997032022A2 Canine ob protein compositions and methods |
| 09/04/1997 | WO1997032020A2 Shc proteins |
| 09/04/1997 | WO1997032019A2 C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses |
| 09/04/1997 | WO1997032018A2 Hepatitis c virus ribozymes |
| 09/04/1997 | WO1997032015A1 Method of purifying thrombin-like protease enzymes obtained from snake venom |
| 09/04/1997 | WO1997031949A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 09/04/1997 | WO1997031948A1 Peptide immunogens for vaccination against and treatment of allergy |
| 09/04/1997 | WO1997031946A1 Il-13 binding chain of il-13 receptor |
| 09/04/1997 | WO1997031945A1 Dna encoding a human imidazoline receptor |
| 09/04/1997 | WO1997031944A1 Fragments of cr1 and their use |
| 09/04/1997 | WO1997031943A1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 09/04/1997 | WO1997031942A1 Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use |
| 09/04/1997 | WO1997031941A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | WO1997031940A1 Isoquinolines useful as analgesics |